LIGAND PHARMACEUTICALS INCORPORATED Unrecognized Tax Benefits that Would Impact Effective Tax Rate
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $20.60 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-27
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $20.60M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $20.70M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $20.60M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $27.30M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-12-31 | $20.60M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $20.70M 10-K · filed 2025-02-28 | |
| 2023-12-31 | $20.60M 10-K · filed 2024-02-29 | |
| 2022-12-31 | $27.30M 10-K · filed 2023-02-28 | |
| 2021-12-31 | $28.10M 10-K · filed 2022-02-28 | |
| 2020-12-31 | $30.20M 10-K · filed 2021-02-24 | |
| 2019-12-31 | $27.10M 10-K · filed 2020-02-27 | |
| 2018-12-31 | $28.20M 10-K · filed 2019-02-28 | |
| 2017-12-31 | $26.80M 10-K · filed 2018-03-01 | |
| 2016-12-31 | $35.50M 10-K · filed 2017-02-28 | |
| 2015-12-31 | $33.50M 10-K · filed 2016-11-14 | $7.60M 10-K · filed 2016-02-26 |